These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14148363)

  • 21. A simple paper test for detecting isoniazid in urine.
    GANGADHARAM PR; NAIR CN; SUBBAIAH TV
    Bull Int Union Tuberc; 1962 Jul; 32():363-5. PubMed ID: 13896636
    [No Abstract]   [Full Text] [Related]  

  • 22. [CHEMO-ANTIBIOTIC THERAPY OF TUBERCULOSIS IN DIABETICS AND ITS REPERCUSSIONS ON GLUCIDE METABOLISM].
    FILLA E; COMENALE D; ROSSI F
    Minerva Med; 1964 Aug; 55():2417-22. PubMed ID: 14192139
    [No Abstract]   [Full Text] [Related]  

  • 23. The mutations of katG and inhA genes of isoniazid-resistant Mycobacterium tuberculosis isolates in Taiwan.
    Tseng ST; Tai CH; Li CR; Lin CF; Shi ZY
    J Microbiol Immunol Infect; 2015 Jun; 48(3):249-55. PubMed ID: 24184004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Streptomycin, dihydrostreptomycin, P.A.S. and isoniazid. Intolerance in the treatment of pulmonary tuberculosis].
    PASTOR MF; HERRERO JJ; LOPEZ MEDRANO CM
    Dia Med; 1962 Aug; 34():1597-9. PubMed ID: 13941745
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pulmonary resections in tuberculosis. The use of isoniazid, ethioniamide, streptomycin and cycloserine].
    MATHEY J; LORO MARCHESE JH
    Rev Asoc Med Argent; 1961 Sep; 75():468-75. PubMed ID: 14471116
    [No Abstract]   [Full Text] [Related]  

  • 26. [THERAPEUTIC ACTIVITY AND TOLERANCE TO SOME COMBINED ANTIBIOTICS IN TUBERCULOSIS].
    RABUKHIN AE
    Antibiotiki; 1963 Jul; 8():645-50. PubMed ID: 14090371
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of simultaneous administration of 5-bromosalicylhydroxamic acid (T40) and INH on the concentration of free INH in urine of tubercular patients].
    Zduńczyk-Pawelek H; Otrzonsek N; Kostrzewska K
    Z Tuberk Erkr Thoraxorg; 1965; 124(3):149-52. PubMed ID: 5899137
    [No Abstract]   [Full Text] [Related]  

  • 28. PRACTICAL METHODS OF DETECTING MAJOR ANTITUBERCULOSIS DRUGS IN THE URINE.
    HOBBY GL
    Bibl Tuberc; 1964; 19():98-120. PubMed ID: 14271078
    [No Abstract]   [Full Text] [Related]  

  • 29. [Excretion of INH, phthivazide and certain other antitubercular drugs with milk].
    GREBENNIK LI; KAIDIN DA; BOGOMOLOVA NS
    Farmakol Toksikol; 1959; 22():362-4. PubMed ID: 13829173
    [No Abstract]   [Full Text] [Related]  

  • 30. [TREATMENT OF PULMONARY TUBERCULOSIS WITH SUBSIDIARY DRUGS].
    GARBULSKY R; RICCHETTI C; BERTOGLIO O; DIFRANCO G
    Sem Med; 1964 Apr; 124():860-2. PubMed ID: 14181020
    [No Abstract]   [Full Text] [Related]  

  • 31. [COMPARATIVE DATA ON PHTHIVAZID AND METHAZID INACTIVATION IN THE BODY OF TUBERCULOSIS PATIENTS].
    SMIRNOV GA; KOZULITSINA TI
    Probl Tuberk; 1964; 42():69-74. PubMed ID: 14229075
    [No Abstract]   [Full Text] [Related]  

  • 32. [EFFECTIVENESS OF THE TREATMENT OF PULMONARY TUBERCULOSIS WITH ANTITUBERCULAR AGENTS IN DIFFERENT CONDITIONS].
    ALIMOV CA
    Bull Int Union Tuberc; 1964 Sep; 35():247-9. PubMed ID: 14269379
    [No Abstract]   [Full Text] [Related]  

  • 33. [THE COMPARATIVE EFFECT OF INH, PHTHIVAZID AND METAZID ON VITAMIN B-6 EXCRETION IN TUBERCULOSIS PATIENTS].
    GREBENNIK LI; EROSHINA NV
    Probl Tuberk; 1963; 41():57-60. PubMed ID: 14069171
    [No Abstract]   [Full Text] [Related]  

  • 34. A CASE OF TUBERCULOUS MENINGITIS DEVELOPED DURING THE COURSE OF CHEMOTHERAPY FOR PULMONARY TUBERCULOSIS.
    VISHNEVSKY-VYSNIAUSKAS C
    Am Rev Respir Dis; 1963 Nov; 88():703-5. PubMed ID: 14082685
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antitubercular activity of the calcium methansulfonate of isonicotinic acid hydrazide].
    FARIAS CE; DI CARLO FC; CAFIRE N; FERNANDEZ H
    Dia Med; 1963 Jun; 35():837-8. PubMed ID: 13944367
    [No Abstract]   [Full Text] [Related]  

  • 36. [Modified method for indicating antitubercular agents in the urine in tuberculosis].
    Solov'eva AS; Lukomskaia VM
    Lab Delo; 1980; (12):756-7. PubMed ID: 6163900
    [No Abstract]   [Full Text] [Related]  

  • 37. [THE EXCRETION OF VISIBLE, BUT NON-VIABLE TUBERCLE BACTERIA DURING CHEMOTHERAPY OF CAVERNOUS PULMONARY TUBERCULOSIS].
    BARTMANN K; SCHUETZ I; VIETINGHOFF-SCHEEL OE
    Prax Pneumol; 1964 May; 18():273-87. PubMed ID: 14213747
    [No Abstract]   [Full Text] [Related]  

  • 38. [TREATMENT TRIALS IN PULMONARY TUBERCULOSIS COMBINING ISONIAZID, ADMINISTERED 2 TIMES A WEEK, AND A THIOCARBANILIDE IN DAILY FORM].
    GOMEZ FD; CUNARRODEGIMENO G
    Rev Esp Tuberc; 1964 May; 33():209-21. PubMed ID: 14169312
    [No Abstract]   [Full Text] [Related]  

  • 39. [The characteristics of the sensitivity of Mycobacterium tuberculosis to rifampicin and isoniazid through determination of mutations in the genes rpoB, katG, inhA, oxyR, and kasA by different molecular biological assays].
    Skotnikova OI; Galkina KIu; Nosova EIu; Krasnova MA; Moroz AM
    Probl Tuberk Bolezn Legk; 2005; (8):42-5. PubMed ID: 16209020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A clinical evaluation of thiocarbanidin and isoniazid in the treatment of pulmonary tuberculosis.
    DONOHOE RF; DUKE CJ; KATZ S; ROMANSKY MJ
    Am Rev Respir Dis; 1959 Oct; 80():590-3. PubMed ID: 13817569
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.